Literature DB >> 11401957

Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.

S Donnelly1, C E Loscher, M A Lynch, K H Mills.   

Abstract

Immunization with the whole-cell pertussis vaccine (Pw), while effective at preventing whooping cough in infants, has been associated with local, systemic, and neuronal reactions, including fevers and convulsions in children. In contrast, the new acellular pertussis vaccines (Pa) have a considerably improved safety profile. The lack of an appropriate animal model has restricted investigations into the mechanisms by which neurological reactions are induced by vaccination. Here we describe a novel murine model wherein seizure-like behavioral changes are induced following parenteral administration of Pw. The proinflammatory cytokine interleukin-beta (IL-1beta), production of which has been associated with many neurodegenerative conditions, was significantly increased in the hippocampus and hypothalamus of vaccinated animals. Accompanying this change was a decrease in release of the inhibitory neurotransmitters gamma-aminobutyric acid and adenosine in the hippocampus. Seizure-like behavioral changes were significantly reduced following inhibition of IL-1beta production by the administration of an inhibitor of IL-1beta-converting enzyme and were almost completely abrogated in IL-1 receptor type I knockout mice. These results suggest a causal relationship between IL-1beta induction and convulsive behavior following Pw vaccination. Significantly, Pa neither increased IL-1beta nor induced behavioral changes in mice, but did induce the anti-inflammatory cytokine IL-10. In contrast, administration of active pertussis toxin and lipopolysaccharide, residual in Pw but absent from Pa, also induced convulsive activity. Our findings provide the first direct evidence of an immunological basis for pertussis vaccine reactogenicity and suggest that active bacterial toxins are responsible for the neurologic disturbances observed in children immunized with Pw.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401957      PMCID: PMC98454          DOI: 10.1128/IAI.69.7.4217-4223.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.

Authors:  P McGuirk; K H Mills
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

2.  Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis.

Authors:  C E Loscher; S Donnelly; M A Lynch; K H Mills
Journal:  J Neuroimmunol       Date:  2000-01-24       Impact factor: 3.478

3.  Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues.

Authors:  F W van Ginkel; R J Jackson; Y Yuki; J R McGhee
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

4.  Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor.

Authors:  A Uehara; P E Gottschall; R R Dahl; A Arimura
Journal:  Endocrinology       Date:  1987-10       Impact factor: 4.736

Review 5.  Annual review prize lecture cytokines - killers in the brain?

Authors:  N J Rothwell
Journal:  J Physiol       Date:  1999-01-01       Impact factor: 5.182

6.  Vaccine visions and their global impact.

Authors:  B R Bloom; R Widdus
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

7.  Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons.

Authors:  S Wang; Q Cheng; S Malik; J Yang
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

8.  Glycerol-induced seizure: involvement of IL-1beta and glutamate.

Authors:  S Donnelly; C Loscher; K H Mills; M A Lynch
Journal:  Neuroreport       Date:  1999-06-23       Impact factor: 1.837

9.  Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae.

Authors:  A Preston; A G Allen; J Cadisch; R Thomas; K Stevens; C M Churcher; K L Badcock; J Parkhill; B Barrell; D J Maskell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

10.  Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.

Authors:  Y Yuhas; L Shulman; A Weizman; E Kaminsky; A Vanichkin; S Ashkenazi
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

View more
  7 in total

1.  A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Authors:  A Dunne; L A Mielke; A C Allen; C E Sutton; R Higgs; C C Cunningham; S C Higgins; K H G Mills
Journal:  Mucosal Immunol       Date:  2014-10-15       Impact factor: 7.313

2.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

3.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

4.  Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS.

Authors:  Cory Teuscher; Meena Subramanian; Rajkumar Noubade; Jian Feng Gao; Halina Offner; James F Zachary; Elizabeth P Blankenhorn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

5.  Diphtheria, pertussis (whooping cough), and tetanus vaccine induced recurrent seizures and acute encephalopathy in a pediatric patient: Possibly due to pertussis fraction.

Authors:  Mahendra K Patel; Tejas K Patel; C B Tripathi
Journal:  J Pharmacol Pharmacother       Date:  2012-01

Review 6.  Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.

Authors:  Anja Saso; Beate Kampmann; Sophie Roetynck
Journal:  Vaccines (Basel)       Date:  2021-08-07

Review 7.  Roads to the development of improved pertussis vaccines paved by immunology.

Authors:  Jolanda Brummelman; Mieszko M Wilk; Wanda G H Han; Cécile A C M van Els; Kingston H G Mills
Journal:  Pathog Dis       Date:  2015-09-06       Impact factor: 3.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.